86. Which of the following products is most likely to be rejected by a reverse distributor?

Answer: D

Explanation:

A medication that has already passed its printed expiration date

Medications that have surpassed their printed expiration date are typically rejected by reverse distributors due to safety and efficacy concerns. Expired medications may not provide the intended therapeutic effect and can pose risks to patients.

A) An unopened stock bottle in the original manufacturer packaging

This option is unlikely to be rejected by a reverse distributor as unopened stock bottles that are still in their original packaging are usually eligible for return. They are considered safe and effective until their expiration date.

B) A partial stock bottle of a medication that will expire within three months

While this option may raise concerns, a partial stock bottle that has not yet expired is generally acceptable for return, especially if it is still within the timeframe for safe use. Reverse distributors may accept such items provided they can be sold before expiration.

C) A medication that was repackaged in unit doses for a nursing home

Repackaged medications in unit doses can be returned, but only if they are within expiration. This option is less likely to be rejected unless there are specific regulatory or safety issues, making it a more acceptable return than expired products.

D) A medication that has already passed its printed expiration date

This option is the most likely to be rejected by a reverse distributor as expired medications cannot be guaranteed to be safe or effective. Thus, they are not accepted in returns to prevent potential harm to patients.

Conclusion

The option regarding the medication that has already passed its printed expiration date is definitively the correct answer, as expired medications pose significant safety risks and are rejected by reverse distributors. In contrast, the other options involve products that are still within acceptable usage limits, highlighting the critical importance of expiration dates in pharmaceutical returns.